Affiner les résultats

Somatostatin-based radiopeptide therapy with [177Lu-DOTA]-TOC versus [90Y-DOTA]-TOC in neuroendocrine tumours

Romer, A. ; Seiler, D. ; Marincek, N. ; Brunner, P. ; Koller, M. ; Ng, Q. ; Maecke, H. ; Müller-Brand, J. ; Rochlitz, C. ; Briel, M. ; Schindler, C. ; Walter, M.

In: European Journal of Nuclear Medicine and Molecular Imaging, 2014, vol. 41, no. 2, p. 214-222

Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial

Cordier, D. ; Forrer, F. ; Bruchertseifer, F. ; Morgenstern, A. ; Apostolidis, C. ; Good, S. ; Müller-Brand, J. ; Mäcke, H. ; Reubi, J. ; Merlo, A.

In: European Journal of Nuclear Medicine and Molecular Imaging, 2010, vol. 37, no. 7, p. 1335-1344

Belastungsabhängige vertikale Doppelbilder und Ptosis = Stress-related vertical double vision and ptosis

Palmowski-Wolfe, A.M. ; Kappos, L. ; Müller-Brand, J. ; Buitrago-Tellez, C. ; Merlo, A.

Situs inversus completus

Walter, M. ; Burger, P. ; Pfisterer, M. ; Müller-Brand, J. ; Zellweger, M.

In: European Journal of Nuclear Medicine and Molecular Imaging, 2003, vol. 30, no. 8, p. 1202-1202

[18F]FDG-PET of giant-cell aortitis

Walter, M. A. ; Melzer, R. A. ; Graf, M. ; Tyndall, A. ; Müller-Brand, J. ; Nitzsche, E. U.

In: Rheumatology, 2005, vol. 44, no. 5, p. 690-691

Ambulatory scintigraphic assessment of transient changes in left ventricular function: a new method for detection of silent myocardial ischaemia

Pfisterer, M. ; Regenass, S. ; Müller-Brand, J. ; Burkart, F.

In: European Heart Journal, 1988, vol. 9, p. 98-103

Plasma potassium in patients with terminal renal failure during and after haemodialysis; relationship with dialytic potassium removal and total body potassium

Blumberg, A. ; Roser, H W. ; Zehnder, C. ; Müller-Brand, J.

In: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1997, vol. 12, no. 8, p. 1629-1634